Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3230-3240
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3230
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3230
Figure 4 represses MAPK activation to inhibit cell apoptosis of colorectal cancer cells.
A: Phosphorylation of JNK and P38 MAPK in CL-40 and SK-CO-1 cells was measured by western blot; B: Flow cytometric analysis of apoptosis of CL-40 and SK-CO-1 cells; C: Detection of apoptosis marker protein (Bax and Bcl-2) in shRNA aldehyde dehydrogenase 2 family member-cells co-treated with Alda-1, SP600125, or SB203580. Data are displayed as the mean ± SD. aP < 0.05, bP < 0.01, cP < 0.001. ALDH2: Aldehyde dehydrogenase 2 family member.
- Citation: Yu M, Chen Q, Lu YP. Aldehyde dehydrogenase 2 family member repression promotes colorectal cancer progression by JNK/p38 MAPK pathways-mediated apoptosis and DNA damage. World J Gastrointest Oncol 2024; 16(7): 3230-3240
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3230.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3230